Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001978964 | SCV002218870 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2Z | 2021-11-21 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MORC2 protein function. This variant has not been reported in the literature in individuals affected with MORC2-related conditions. This variant is present in population databases (rs776665575, gnomAD 0.006%). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 556 of the MORC2 protein (p.Thr556Met). |
Prevention |
RCV003418229 | SCV004108625 | uncertain significance | MORC2-related disorder | 2023-04-10 | criteria provided, single submitter | clinical testing | The MORC2 c.1667C>T variant is predicted to result in the amino acid substitution p.Thr556Met. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |